Stock Movers: Novo Nordisk Rallies on Pill Approval, ServiceNow Acquires Armis, Sable Pipeline Restarted

Novo Nordisk's Obesity Pill Approval

• 🚀 Novo Nordisk (NVO) shares surged by 7.3%, marking the biggest jump since August 2023.
• 💡 This rally was driven by the US approval of a pill version of its Wegovy obesity drug, set to launch in January.
• 🎯 The oral drug is seen as crucial for Novo Nordisk to compete with Eli Lilly, which has a similar drug potentially approved by March.
• 📉 Eli Lilly's stock saw a relatively flat movement, down 0.5%, indicating market anticipation of the competition.

ServiceNow's Major Acquisition

• 🏢 ServiceNow (NOW), an enterprise tech company, is acquiring cybersecurity startup Armis for $7.75 billion, its largest acquisition to date.
• 💰 The deal, expected to close in the second half of 2026, will be funded through cash and debt.
• 🔒 Armis specializes in identifying threats across various industries, making it a strategic acquisition for ServiceNow's workflow platform.
• 📊 Analysts, like those at Evercore, suggest the acquisition will not significantly stress ServiceNow's strong free cash flow, projected at $5 billion in 2025.

Sable Offshore's Pipeline Restart

• 📈 Sable Offshore (SOC) shares jumped by 36% following approval from the US Department of Transportation for its Las Flores pipeline restart plan.
• ⚠️ The pipeline, located in California, had a significant oil leak about a decade ago.
• 🗓️ This approval is a critical step, allowing Sable to sell oil as early as 2026, a year ahead of previous expectations.
• 📉 Despite today's gains, Sable shares remain down 54% on a 12-month basis, reflecting the volatility in the energy sector.

IPO Market Performance

• 🌟 The IPO market has been significantly boosted by the recent IPO of Medline, the largest this year.
• 📊 Medline's stock is up 50% since its IPO about a week ago, improving the overall IPO performance for 2025, which was previously below the S&P 500.
• 🚀 A robust IPO pipeline is anticipated for the upcoming year.